Aptorum Group [APM] to Ring the NASDAQ Stock Market Closing Bell in Celebration of IPO Closing
HONG KONG--(BUSINESS WIRE)--Dec 18, 2018--Aptorum Group Limited (“APM”), a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing therapeutic projects and diagnostic technologies to tackle unmet medical needs, announced today that its management will visit the Nasdaq MarketSite in Times Square, in celebration of the closing of its initial public offering (IPO).
In honor of the occasion, Ian Huen, Founder and Chief Executive Officer of APM, will ring the Closing Bell.
Nasdaq MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Tuesday, December 18, 2018 – 3:45 p.m. to 4:00 p.m. ET
A live webcast of the NASDAQ Closing Bell will be available at: https://new.livestream.com/nasdaq/live
To obtain a hi-resolution photograph of the Market Close, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market close of your choice.
About Aptorum Group Limited [APM]
We are a Hong Kong based pharmaceutical company currently in the preclinical stage, dedicated to developing and commercializing a broad range of therapeutic and diagnostic technologies to tackle unmet medical needs. We have obtained exclusive licenses for our technologies. In addition, we are also developing certain proprietary technologies as product candidates. We are pursuing therapeutic and diagnostic projects (including projects seeking to use extracts or derivatives from natural substances to treat diseases) in neurology, infectious diseases, gastroenterology, oncology and other disease areas. We also have projects focused on surgical robotics. In addition, we opened a medical clinic, AML Clinic, in June 2018. Its initial focus is on treatment of chronic diseases resulting from modern sedentary lifestyles and aging population. For more information about the Company, please visit www.aptorumgroup.com.
Nasdaq (Nasdaq:NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today’s global capital markets. As the creator of the world’s first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world’s securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181217005878/en/
Sabrina Khan, CFO
+852 2117 6611
KEYWORD: UNITED STATES ASIA PACIFIC NORTH AMERICA NEW YORK HONG KONG
INDUSTRY KEYWORD: SURGERY HEALTH CLINICAL TRIALS INFECTIOUS DISEASES ONCOLOGY PHARMACEUTICAL RESEARCH SCIENCE
SOURCE: Aptorum Group Limited
Copyright Business Wire 2018.
PUB: 12/18/2018 03:42 AM/DISC: 12/18/2018 03:42 AM